Company: HCTI
Filing Date: 2025-10-08
Form Type: 8-K
Source: 0001213900-25-097464
Chunk: 1

Company: Healthcare Triangle, Inc.
Filing Date: 2025-10-08
Form: 8-K
Item: Item 1.01
Chunk 1
---
 longer own any New Warrants or New Warrant Shares.

The Company expects to use the net proceeds from
these transactions for working capital and other general corporate purposes.

WallachBeth Capital, LLC acted as the financial
advisor (the “ Financial Advisor”) on a “reasonable best efforts” basis, in connection with the Warrant Inducement
to a financial advisory agreement, dated October 2, 2025, by and between the Company and the Financial Advisor (“ Letter of Engagement”).
Pursuant to the Letter of Engagement, the Financial Advisor received a cash fee of 6.0% of the aggregate gross proceeds paid to the Company
for the securities sold in the Warrant Inducement and reimbursement of certain out-of-pocket expenses up to a maximum of $20,000. As additional
compensation to the Financial Advisor in connection with the Warrant Inducement, the Company agreed to issue to the designees of the Financial
Advisor, warrants (“ Advisor Warrants”) to purchase shares of Common Stock (the “ Advisor Warrant Shares”), equal
to approximately 2.0% of the number of New Warrant Shares issued in the offering, at an exercise price per share equal to $3.00, which
is equal to the exercise price of the New Warrants. The Advisor Warrants have substantially the same terms as the New Warrants. In addition, pursuant to the terms
of the Letter of Engagement, the Financial Advisor has the right of first refusal for a period of six (6) months after the Closing Date
to participate in each and every future public and private equity and debt offerings of the Company, or any successor to or any subsidiary
of the Company in any U. S. stock exchange during such six (6) month period.

Terms of the New Warrants